Mar 06,2026
NBS/NCS Demand Grows Driven by Pharmaceuticals and Water Treatment
Driven by the rapid development of the global pharmaceutical industry and rising environmental standards, N-halogenated succinimide products (NBS, NCS, NIS) are experiencing new growth opportunities.
In pharmaceuticals, these products serve as critical organic synthesis intermediates for R&D and production of innovative drugs, including anti-tumor and anti-HIV therapies. Data shows that pharmaceutical-grade succinimide has grown at over 10% annually, with sustained downstream demand.
In water treatment, N-halogenated reagents are replacing traditional halogen disinfectants due to their high efficiency and low toxicity, with market penetration reaching 28.6%. This trend boosts demand while raising requirements for manufacturers’ environmental and quality control capabilities.
With years of technical expertise and strict quality management, Nanjing Suru Chemical is a core supplier to global pharmaceutical and water treatment projects. We will continue to invest in R&D and optimize product structures to meet evolving market needs.
AR
BG
CS
DA
NL
FI
FR
DE
EL
HI
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
TL
ID
LT
SR
SL
UK
ET
HU
TH
TR
FA
MS
GA
BN
BS
LO
LA
NE
MY